Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Quantification of Upper Extremity Hypertonia

This study has been completed.
Information provided by (Responsible Party):
Terence Sanger, University of Southern California Identifier:
First received: January 31, 2006
Last updated: March 11, 2013
Last verified: March 2013
Dr. Sanger and the research team want to learn about upper extremity hypertonia (stiffness) in children and young adults with cerebral palsy. Specifically, they want to learn about ways to measure the stiffness in the joints of hypertonic arms. The information the research team will collect includes any physical exams or computer generated data about your arm movements.

Condition Phase
Muscle Hypertonia
Phase 1
Phase 2

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Quantification of Upper Extremity Hypertonia

Resource links provided by NLM:

Further study details as provided by University of Southern California:

Primary Outcome Measures:
  • Observation [ Time Frame: 1 hour ] [ Designated as safety issue: No ]

Enrollment: 60
Study Start Date: January 2006
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   4 Years and older   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Children with cerebral palsy and/or dystonia.

Inclusion Criteria:Dystonia in at least one arm Age 4 to no upper limit

Exclusion Criteria:increased risk of participation botulinum toxin within 6 months

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00285870

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
University of Southern California
Principal Investigator: Terence D. Sanger Stanford University
  More Information

Responsible Party: Terence Sanger, Associate Professor, University of Southern California Identifier: NCT00285870     History of Changes
Study First Received: January 31, 2006
Last Updated: March 11, 2013
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Muscle Hypertonia
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Neuromuscular Manifestations processed this record on October 21, 2016